Strategic partnerships Syrris collaborates with major pharma players (e.g., Faes Farma) on flow chemistry systems, indicating openness to joint development and co‑marketing efforts that can be expanded to other pharmaceutical partners seeking advanced flow and reaction calorimetry capabilities.

Global leadership in flow Position Syrris as the world leader in flow chemistry and reaction calorimetry for R&D labs, offering a compelling value proposition to Tier 1 pharmaceutical, chemical, and食品 sectors pursuing scalable, automated chemistry platforms.

Integrated product suite With Atlas HD, Asia, Orb, and Orb Pilot plus syringe pumps, there is a clear opportunity to sell bundled automation and modular reactor solutions to labs investing in scale‑up, crystallization, and process safety—target teams moving from small‑scale discovery to pilot/scale processes.

Expansion through academia Syrris’ adoption in top academic institutions and focus on process development and drug discovery suggests a channel to universities and research consortia for pilot programs, training partnerships, and sponsored research that can convert into commercial customers.

Export and export awards Historical recognition for export achievement (UKTI Best Established Exporter, Global Opportunity Conference) signals strong international sales capability; leverage this track record to engage regional distributors and multinational buyers seeking proven, globally supported flow chemistry solutions.